nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Nandrolone decanoate—MAOB—Parkinson's disease	0.0448	0.449	CrCbGaD
Etonogestrel—SHBG—hindbrain—Parkinson's disease	0.0434	0.112	CbGeAlD
Etonogestrel—PGR—hindbrain—Parkinson's disease	0.0391	0.101	CbGeAlD
Etonogestrel—PGR—Nuclear Receptors—NR4A2—Parkinson's disease	0.0329	0.0642	CbGpPWpGaD
Etonogestrel—Nandrolone decanoate—MAOA—Parkinson's disease	0.0314	0.315	CrCbGaD
Etonogestrel—ESR1—hindbrain—Parkinson's disease	0.0306	0.0788	CbGeAlD
Etonogestrel—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0279	0.0544	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.026	0.0507	CbGpPWpGaD
Etonogestrel—SHBG—brainstem—Parkinson's disease	0.0249	0.0641	CbGeAlD
Etonogestrel—PGR—Nuclear signaling by ERBB4—GFAP—Parkinson's disease	0.021	0.041	CbGpPWpGaD
Etonogestrel—SHBG—cardiovascular system—Parkinson's disease	0.0203	0.0523	CbGeAlD
Etonogestrel—ESR1—Nuclear Receptors—NR4A2—Parkinson's disease	0.0193	0.0377	CbGpPWpGaD
Etonogestrel—ESR1—embryo—Parkinson's disease	0.0191	0.0493	CbGeAlD
Etonogestrel—PGR—cardiovascular system—Parkinson's disease	0.0183	0.0471	CbGeAlD
Etonogestrel—ESR1—brainstem—Parkinson's disease	0.0175	0.0452	CbGeAlD
Etonogestrel—ESR1—forebrain—Parkinson's disease	0.0169	0.0436	CbGeAlD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0152	0.0298	CbGpPWpGaD
Etonogestrel—ESR1—cardiovascular system—Parkinson's disease	0.0143	0.0369	CbGeAlD
Etonogestrel—SHBG—central nervous system—Parkinson's disease	0.0126	0.0323	CbGeAlD
Etonogestrel—PGR—head—Parkinson's disease	0.0124	0.0319	CbGeAlD
Etonogestrel—ESR1—Nuclear signaling by ERBB4—GFAP—Parkinson's disease	0.0123	0.024	CbGpPWpGaD
Etonogestrel—SHBG—cerebellum—Parkinson's disease	0.0123	0.0316	CbGeAlD
Etonogestrel—PGR—nervous system—Parkinson's disease	0.0117	0.0303	CbGeAlD
Etonogestrel—PGR—central nervous system—Parkinson's disease	0.0113	0.0291	CbGeAlD
Etonogestrel—PGR—cerebellum—Parkinson's disease	0.0111	0.0285	CbGeAlD
Etonogestrel—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.01	0.0196	CbGpPWpGaD
Etonogestrel—SHBG—brain—Parkinson's disease	0.00996	0.0257	CbGeAlD
Etonogestrel—ESR1—LKB1 signaling events—MAPT—Parkinson's disease	0.0098	0.0191	CbGpPWpGaD
Etonogestrel—ESR1—head—Parkinson's disease	0.00969	0.025	CbGeAlD
Etonogestrel—Testosterone—MAOA—Parkinson's disease	0.00932	0.0935	CrCbGaD
Etonogestrel—ESR1—nervous system—Parkinson's disease	0.00918	0.0237	CbGeAlD
Etonogestrel—PGR—brain—Parkinson's disease	0.00898	0.0231	CbGeAlD
Etonogestrel—ESR1—AP-1 transcription factor network—PENK—Parkinson's disease	0.00897	0.0175	CbGpPWpGaD
Etonogestrel—ESR1—central nervous system—Parkinson's disease	0.00884	0.0228	CbGeAlD
Etonogestrel—ESR1—cerebellum—Parkinson's disease	0.00864	0.0223	CbGeAlD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—IL1B—Parkinson's disease	0.0085	0.0166	CbGpPWpGaD
Etonogestrel—ESR1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.00801	0.0156	CbGpPWpGaD
Etonogestrel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00775	0.0151	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—SOD1—Parkinson's disease	0.00769	0.015	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—HSPA1A—Parkinson's disease	0.00734	0.0143	CbGpPWpGaD
Etonogestrel—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00717	0.014	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—GFAP—Parkinson's disease	0.00707	0.0138	CbGpPWpGaD
Etonogestrel—ESR1—brain—Parkinson's disease	0.00702	0.0181	CbGeAlD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00688	0.0134	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—TNF—Parkinson's disease	0.00617	0.012	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—FGF20—Parkinson's disease	0.00613	0.012	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.00609	0.0119	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—Parkinson's disease	0.00592	0.0116	CbGpPWpGaD
Etonogestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00577	0.0113	CbGpPWpGaD
Etonogestrel—Ethinyl Estradiol—ABCB1—Parkinson's disease	0.00569	0.0571	CrCbGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—TH—Parkinson's disease	0.00555	0.0108	CbGpPWpGaD
Etonogestrel—Norethindrone—ABCB1—Parkinson's disease	0.00548	0.0549	CrCbGaD
Etonogestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00528	0.0103	CbGpPWpGaD
Etonogestrel—CYP3A4—nervous system—Parkinson's disease	0.00512	0.0132	CbGeAlD
Etonogestrel—CYP3A4—central nervous system—Parkinson's disease	0.00493	0.0127	CbGeAlD
Etonogestrel—ESR1—AP-1 transcription factor network—TH—Parkinson's disease	0.00484	0.00946	CbGpPWpGaD
Etonogestrel—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00483	0.00942	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00477	0.00931	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00475	0.00927	CbGpPWpGaD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00464	0.00906	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—Parkinson's disease	0.00451	0.00881	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00449	0.00876	CbGpPWpGaD
Etonogestrel—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00441	0.00862	CbGpPWpGaD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00425	0.00829	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—GFAP—Parkinson's disease	0.00415	0.0081	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—ABL1—Parkinson's disease	0.0041	0.00801	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00398	0.00777	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00396	0.00774	CbGpPWpGaD
Etonogestrel—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00392	0.00766	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—INS—Parkinson's disease	0.00384	0.00749	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00381	0.00744	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00364	0.00711	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—FGF20—Parkinson's disease	0.0036	0.00702	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00358	0.00699	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00334	0.00651	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PRKRA—Parkinson's disease	0.00307	0.00599	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—INS—Parkinson's disease	0.00304	0.00593	CbGpPWpGaD
Etonogestrel—Testosterone—ABCB1—Parkinson's disease	0.00302	0.0303	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00297	0.0058	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00289	0.00564	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00263	0.00514	CbGpPWpGaD
Etonogestrel—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00237	0.00462	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00227	0.00443	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00225	0.0044	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00219	0.00427	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00217	0.00423	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—TAF1—Parkinson's disease	0.00216	0.00422	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NR4A2—Parkinson's disease	0.00216	0.00422	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK8—Parkinson's disease	0.00208	0.00406	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00202	0.00395	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00201	0.00392	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.002	0.00391	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VPS35—Parkinson's disease	0.00199	0.00389	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00198	0.00386	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—IL1B—Parkinson's disease	0.00187	0.00365	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00183	0.00358	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00181	0.00353	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PRKRA—Parkinson's disease	0.0018	0.00351	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00179	0.0035	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00177	0.00345	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00174	0.00339	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPL6—Parkinson's disease	0.00173	0.00337	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK8—Parkinson's disease	0.00171	0.00335	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GPR37—Parkinson's disease	0.00165	0.00323	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DGKQ—Parkinson's disease	0.00165	0.00323	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00162	0.00317	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00157	0.00306	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00151	0.00295	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00149	0.0029	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—Parkinson's disease	0.00133	0.00259	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RIT2—Parkinson's disease	0.00132	0.00258	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPL14—Parkinson's disease	0.00131	0.00256	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPL23A—Parkinson's disease	0.00131	0.00256	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.0013	0.00254	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00128	0.00251	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—TAF1—Parkinson's disease	0.00127	0.00248	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR4A2—Parkinson's disease	0.00127	0.00248	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRK5—Parkinson's disease	0.00125	0.00244	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00122	0.00239	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPS8—Parkinson's disease	0.00122	0.00238	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00119	0.00232	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VPS35—Parkinson's disease	0.00117	0.00228	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00116	0.00227	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—Parkinson's disease	0.00116	0.00226	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRM4—Parkinson's disease	0.00112	0.00219	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00107	0.00208	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PENK—Parkinson's disease	0.00106	0.00208	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAG—Parkinson's disease	0.00106	0.00208	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6—Parkinson's disease	0.00106	0.00207	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL6—Parkinson's disease	0.00101	0.00198	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HSPA8—Parkinson's disease	0.000978	0.00191	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CTGF—Parkinson's disease	0.000974	0.0019	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDYN—Parkinson's disease	0.000974	0.0019	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DGKQ—Parkinson's disease	0.00097	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GPR37—Parkinson's disease	0.00097	0.00189	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GFAP—Parkinson's disease	0.000916	0.00179	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRM5—Parkinson's disease	0.000905	0.00177	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HSPA1A—Parkinson's disease	0.000891	0.00174	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000887	0.00173	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000883	0.00172	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000863	0.00168	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000851	0.00166	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000812	0.00158	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF20—Parkinson's disease	0.000794	0.00155	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000789	0.00154	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000778	0.00152	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000775	0.00151	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADORA2A—Parkinson's disease	0.00077	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000768	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000768	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.000735	0.00143	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPS8—Parkinson's disease	0.000717	0.0014	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INSR—Parkinson's disease	0.00071	0.00139	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGB—Parkinson's disease	0.000671	0.00131	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HTR1A—Parkinson's disease	0.000668	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRM4—Parkinson's disease	0.000659	0.00129	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TAC1—Parkinson's disease	0.000658	0.00128	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000654	0.00128	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000651	0.00127	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000649	0.00127	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000645	0.00126	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DRD1—Parkinson's disease	0.000645	0.00126	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000642	0.00125	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000642	0.00125	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAG—Parkinson's disease	0.000625	0.00122	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PENK—Parkinson's disease	0.000625	0.00122	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DRD3—Parkinson's disease	0.000625	0.00122	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	0.000622	0.00121	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000598	0.00117	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00059	0.00115	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRBK1—Parkinson's disease	0.000583	0.00114	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPA8—Parkinson's disease	0.000574	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CTGF—Parkinson's disease	0.000572	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDYN—Parkinson's disease	0.000571	0.00112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HTR7—Parkinson's disease	0.000565	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DRD2—Parkinson's disease	0.000565	0.0011	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GFAP—Parkinson's disease	0.000537	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRM5—Parkinson's disease	0.000531	0.00104	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPA1A—Parkinson's disease	0.000523	0.00102	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF2—Parkinson's disease	0.000473	0.000924	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF20—Parkinson's disease	0.000466	0.00091	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1R—Parkinson's disease	0.000458	0.000894	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDN1—Parkinson's disease	0.000452	0.000883	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000452	0.000882	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000424	0.000828	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000424	0.000828	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INSR—Parkinson's disease	0.000417	0.000814	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NGF—Parkinson's disease	0.000416	0.000812	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000399	0.000779	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000399	0.000779	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HTR2A—Parkinson's disease	0.000396	0.000773	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGB—Parkinson's disease	0.000394	0.000769	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000392	0.000765	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TAC1—Parkinson's disease	0.000386	0.000754	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DRD1—Parkinson's disease	0.000379	0.000739	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000378	0.000738	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOE—Parkinson's disease	0.000368	0.000718	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DRD3—Parkinson's disease	0.000367	0.000716	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000361	0.000704	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000342	0.000668	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HTR7—Parkinson's disease	0.000332	0.000647	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DRD2—Parkinson's disease	0.000332	0.000647	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000321	0.000628	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000321	0.000628	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000321	0.000628	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INS—Parkinson's disease	0.000314	0.000614	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF2—Parkinson's disease	0.000278	0.000542	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000269	0.000525	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDN1—Parkinson's disease	0.000265	0.000518	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NGF—Parkinson's disease	0.000244	0.000476	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000236	0.000461	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—Parkinson's disease	0.000234	0.000457	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000232	0.000453	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000223	0.000435	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOE—Parkinson's disease	0.000216	0.000422	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK8—Parkinson's disease	0.000215	0.00042	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000201	0.000392	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000199	0.000388	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INS—Parkinson's disease	0.000184	0.00036	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000148	0.000288	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000145	0.000283	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—Parkinson's disease	0.000137	0.000268	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—Parkinson's disease	0.000137	0.000268	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000135	0.000264	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000133	0.000261	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TH—Parkinson's disease	0.000132	0.000257	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000126	0.000247	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	0.000126	0.000246	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000112	0.000218	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000111	0.000217	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000111	0.000217	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.00011	0.000214	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000105	0.000206	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.000102	0.0002	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.8e-05	0.000191	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.04e-05	0.000177	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOE—Parkinson's disease	8.42e-05	0.000164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—Parkinson's disease	8.06e-05	0.000157	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—INS—Parkinson's disease	7.19e-05	0.00014	CbGpPWpGaD
